AI won't crack rare diseases' #1 bottleneck: uncharacterized causal mechanisms
anshulkundaje · x · 2026-11-07
Stanford professor Anshul Kundaje responds to a builder-parent arguing AI will ease rare-disease diagnostics: the real #1 bottleneck is identifying causal variants, genes and mechanisms—most never characterized, and neither humans nor LLMs can reason their way through completely unknown mechanisms. Treatment may benefit more from intelligence plus parallelized experiments.
Related event: Stanford professor argues rare disease bottleneck is biology, not AI(10 posts)→
More from AGI Musings
- In the applied AI era, prior knowledge and years of skill-building no longer block outcomes — brandon_galang · 2026-11-08
- Founder: We hired a dev for testing in January — now agents do that job — adamamcbride · 2026-11-08
- UK Banks Keep Hiring as Promised AI Benefits Fail to Materialize — HotMinuteUK · 2026-11-08
- Kambhampati: Frontier models' 'jagged intelligence' traces back to opaque training data mixes — rao2z · 2026-11-08
- Theorizing that AI will do 99.9999% of work ignores how vast remaining human work will be — timigod · 2026-11-08
- DeepMind economist: millions of AI agents could leave GDP growth stuck at 4-5% — AlexTamkin · 2026-11-08